Related Experiment Videos
Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery
B N Noureddin1, N Wilson-Holt, M Lavin
1Glaucoma Unit, Moorfields Eye Hospital, London, England.
Ophthalmology
|March 1, 1992
Summary
Comparing glaucoma surgeries, tube implantation required fewer medications than neodymium:YAG (Nd:YAG) cyclophotocoagulation. However, laser treatment was repeated in nearly half of cases, especially in younger patients.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Glaucoma Management
Background:
- Advanced uncontrolled glaucoma presents significant challenges for intraocular pressure (IOP) management.
- Traditional surgical interventions often have limitations or complications.
- Neodymium:YAG (Nd:YAG) cyclophotocoagulation and tube implantation are established treatments for refractory glaucoma.
Purpose of the Study:
- To compare the efficacy and outcomes of noncontact neodymium:YAG (Nd:YAG) cyclophotocoagulation versus tube implantation surgery in patients with advanced uncontrolled glaucoma.
- To evaluate intraocular pressure reduction, medication requirements, and need for further interventions.
- To identify risk factors associated with treatment response.
Main Methods:
- A matched-pair study comparing 45 patients undergoing Nd:YAG cyclophotocoagulation with 45 patients receiving tube implantation.
- Matching criteria included diagnosis, prior ocular surgeries, aphakia, vitrectomy, and age.
- Follow-up assessments included intraocular pressure, medication use, and need for additional surgical intervention over 12 months.
Main Results:
- Both Nd:YAG cyclophotocoagulation and tube implantation achieved statistically significant IOP reduction at all follow-up points (P < 0.001).
- Tube implantation patients required fewer antiglaucoma medications at 1 year (P < 0.025).
- Nd:YAG cyclophotocoagulation required retreatment in 49% of cases, with younger age (<40 years) identified as a risk factor for poorer outcomes.
Conclusions:
- Both surgical techniques are effective in lowering IOP in advanced glaucoma.
- Tube implantation may offer an advantage in reducing medication burden.
- Nd:YAG cyclophotocoagulation may require repeat procedures, particularly in younger patients, necessitating careful consideration of treatment strategies.